Today, Lilly is generating potential biotech solutions (using therapeutic proteins or antibodies to treat disease), alongside more traditional chemistry-based work to deliver innovative treatments for a wide range of diseases, including cancer, multiple sclerosis, diabetes, osteoporosis, rheumatoid arthritis, and Alzheimer's disease.